SentinelOne (S) is down 3.1% today. Here is some analysis on what might have caused this price movement.
Analysis: A single clear catalyst is not obvious today, but the decline appears tied to a mix of profit-taking and investor digestion of recent insider-sale disclosures and financing activity. This could be because the stock had been trading near recent highs, leaving shares more vulnerable to a pullback even though the company’s last earnings update was strong.
Details:
Sources:
SentinelOne Investor Relations, SEC, Google Finance
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$S Insider Trading Activity
$S insiders have traded $S stock on the open market 34 times in the past 6 months. Of those trades, 0 have been purchases and 34 have been sales.
Here’s a breakdown of recent trading of $S stock by insiders over the last 6 months:
- TOMER WEINGARTEN (President, CEO) has made 0 purchases and 10 sales selling 1,057,152 shares for an estimated $23,042,206.
- SONALEE ELIZABETH PAREKH (Chief Financial Officer) has made 0 purchases and 5 sales selling 136,481 shares for an estimated $2,986,276.
- KEENAN MICHAEL CONDER (Chief Legal Officer & Sec'y) has made 0 purchases and 4 sales selling 68,617 shares for an estimated $1,385,378.
- ROBIN TOMASELLO (Chief Accounting Officer) has made 0 purchases and 7 sales selling 60,402 shares for an estimated $1,165,917.
- BARRY L. PADGETT (President and COO) has made 0 purchases and 4 sales selling 50,162 shares for an estimated $1,071,998.
- ANA G. PINCZUK (President Product & Technology) has made 0 purchases and 4 sales selling 44,344 shares for an estimated $950,595.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$S Hedge Fund Activity
We have seen 254 institutional investors add shares of $S stock to their portfolio, and 240 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC removed 4,981,533 shares (-67.3%) from their portfolio in Q2 2026, for an estimated $84,536,615
- FIRST TRUST ADVISORS LP added 4,401,726 shares (+40.2%) to their portfolio in Q3 2026, for an estimated $104,585,009
- SYLEBRA CAPITAL LLC removed 3,718,309 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $63,099,703
- AQR CAPITAL MANAGEMENT LLC added 3,560,270 shares (+18.0%) to their portfolio in Q2 2026, for an estimated $60,417,781
- WELLINGTON MANAGEMENT GROUP LLP added 3,428,192 shares (+216.0%) to their portfolio in Q2 2026, for an estimated $58,176,418
- D. E. SHAW & CO., INC. added 3,368,067 shares (+2292.3%) to their portfolio in Q2 2026, for an estimated $57,156,096
- J. GOLDMAN & CO LP added 3,344,503 shares (+inf%) to their portfolio in Q2 2026, for an estimated $56,756,215
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$S Price Targets
Multiple analysts have issued price targets for $S recently. We have seen 14 analysts offer price targets for $S in the last 6 months, with a median target of $20.0.
Here are some recent targets:
- Patrick Colville from Scotiabank set a target price of $23.5 on 07/06/2026
- Catharine Trebnick from Rosenblatt set a target price of $20.0 on 07/01/2026
- Jonathan Ruykhaver from Cantor Fitzgerald set a target price of $24.0 on 05/29/2026
- Roger Boyd from UBS set a target price of $16.0 on 05/29/2026
- Kingsley Crane from Canaccord Genuity set a target price of $18.0 on 05/29/2026
- Rudy Kessinger from DA Davidson set a target price of $15.0 on 05/29/2026
- Saket Kalia from Barclays set a target price of $16.0 on 05/29/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.